Aardvark Therapeutics, Inc.（AARD）價格預測AARDAardvark Therapeutics, Inc.

Alphio's AARD stock price prediction model matches the current Aardvark Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.76 (-2.54%). The 1-week path is $3.67 (-4.86%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Aardvark Therapeutics is not a good buy right now due to significant financial losses and regulatory challenges. The current price is $4.76, and the company reported a net loss of $14.4 million in Q2 2026, indicating ongoing financial distress. Additionally, the stock has dropped 63.91% year-to-date, reflecting a lack of investor confidence, especially after the FDA placed its lead program on clinical hold. The main risk is the uncertainty surrounding the clinical hold, which could further impact future funding and development opportunities.

Aardvark Therapeutics, Inc. (AARD) last closed at $3.86, losing -0.52%. These facts feed the 1-day and 1-week AARD price prediction above.